Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection

By T. Baba, V. Liška, R. Hofmann-Lehmann, J. Vlasák, Weidong Xu, S. Ayehunie, L. Cavacini, M. Posner, H. Katinger, G. Stiegler and 9 more. Nature Medicine, 2000

924 citations recorded by the source corpus.

Subfields: Infectious Diseases, Virology

View Paper: https://www.semanticscholar.org/paper/387cfc3e113d96cdc33157f46b3a8f67045e556a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. T. Chou
2. J. Piggott

Citations in the corpus

• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies (2006, background): “…simianhuman immunodeficiency virus. c. Prevention of HIV infection in vivo: Ruprecht et al. (1990), AZT IFN against retroviral viremia in mice; Baba et al. (2000) hMAbs of IgG1 combinations against simian-human immunodeficiency virus infection; Hofmann-Lehmann et al. (2001a,b), passive…”